CollPlant Secures $2.6M Private Placement with Significant Dilution
CLGN sits 27% above its 52-week low of $0.271.
Summary
CollPlant Biotechnologies raised $2.6 million through a private placement of shares and warrants, providing crucial capital but at a significant dilutive cost to existing shareholders.
Key Events · Financing and Capital Events · CLGN
-
Capital Raise
CollPlant secured $2.6 million in gross proceeds through a private placement of ordinary shares and accompanying warrants.
-
Significant Dilution
The offering includes 7,647,061 ordinary shares and warrants to purchase an additional 23,399,907 ordinary shares (comprising Series A, Series B, and Placement Agent Warrants), representing substantial potential dilution.
-
Pricing Details
The combined purchase price for each ordinary share and accompanying warrants was $0.34, which is closely aligned with the current market price of $0.343.
-
Use of Proceeds
Net proceeds are intended for general corporate purposes, including working capital, funding research and development programs, and evaluating strategic business combinations.
Analysis · CLGN · Industrial Applications And Services
This private placement provides a critical capital infusion of $2.6 million for CollPlant Biotechnologies, a company that recently reported extremely poor financial results and a going concern warning. While the capital is essential for operations and R&D, the offering involves substantial dilution, with 7.6 million ordinary shares and warrants to purchase an additional 23.4 million shares (Series A, Series B, and Placement Agent Warrants) at a combined price of $0.34, very close to the current market price. This capital raise, representing over 50% of the company's market capitalization, is a necessary but highly dilutive measure to extend the company's operational runway amidst significant financial challenges.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 49.5% of the 190 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLGN was trading at $0.34 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.27 to $3.23. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.